계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Immunophage Biotech
company
About
Immunophage Biotech is a Nanjing-based pharmaceutic company.
- 11 - 50
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $14.20M
- Industries
- Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Immunophage Biotech is a Chinese high-tech pharmaceutic company which was established in 2016. The R&D center of the company is located in the Pujiang High-Tech Park, Shanghai, China. They are developing first-in-class immune-regulating medicines against cancer, autoimmune diseases and neurodegenerative disorders.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$14.20M
Immunophage Biotech has raised a total of
$14.20M
in funding over 2 rounds. Their latest funding was raised on
Sep 28, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 28, 2021 | Series A | — | 1 | — | — | Detail |
| May 5, 2020 | Seed | $14.20M | 6 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
7
Immunophage Biotech is funded by 7 investors.
Jinfang Hongrui Investment Management
and Renjin Ziben
are the most recent investors.
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
